Apr 19, 2019 | Online Services, Reporting, Rx Costs, Rx Spending, Savings
To give employers the most accurate and up-to-date information possible, MedBen has partnered with Deerwalk, Inc. to provide an upgraded data analytics and reporting platform. The strong reporting that MedBen clients come to expect is now even stronger. With our...
Apr 5, 2019 | Overprescribing, Rx Costs, Rx Spending
The ongoing movement to reduce prescription drug spending focuses primarily on the cost factor. But as Shannon Brownlee and Judith Garber contend in a Stat opinion piece, overprescribing of drugs also carries financial and health risks. “Between 2000 and 2012,...
Mar 25, 2019 | Average Wholesale Price, MedBen Rx, Pharmacies, Pharmacy Benefits Manager (PBM), Rebates, Rx Costs, Rx Spending, Transparency
In just four years, U.S. retail prescription drug spending grew nearly 27%… a substantial increase that illustrates the need for pharmacy solutions like those available through MedBen Rx. A new report from the Pew Charitable Trusts found that annual spending on...
Feb 28, 2019 | Government, Legislation, MedBen Rx, Rx Costs, Rx Spending, Specialty Drugs
A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it’s why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As...
Jan 16, 2019 | Average Wholesale Price, Brand Name Drugs, Discounts, Generic Drugs, MedBen Rx, Rx Costs, Rx Spending, Savings
New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to previous years,...
Nov 21, 2018 | MedBen Rx, Rebates, Rx Costs, Rx Spending, Savings, Specialty Drugs
A New York Times article examines the dramatic rise in U.S. prescription drug costs over the past two decades. American drug spending was once on par with other wealthy countries, but between 1997 and 2007 our drug spending tripled… and took off again in 2013....
